KLOW 80 MG

KLOW 80 mg is a multi-peptide research blend formulated with the following components:

• GHK-CU – 50 mg
• TB-500 (Thymosin Beta-4 fragment) – 10 mg
• BPC-157 – 10 mg
• KPV – 10 mg

This combination has been studied in laboratory research for its potential interaction with inflammatory signaling pathways, tissue repair mechanisms, extracellular matrix regulation, and cellular communication processes.

Multi-peptide blends are commonly evaluated in controlled research environments to observe how complementary compounds may influence structural protein signaling, vascular pathways, immune modulation, and connective tissue resilience.

What the Research Shows

Research on the individual components of KLOW 80 mg has explored their roles across recovery, inflammatory balance, and tissue remodeling pathways.

GHK-CU (50 mg)
Studied for its influence on collagen signaling, extracellular matrix activity, antioxidant pathways, and tissue remodeling mechanisms. Research has examined its role in structural protein regulation and cellular repair signaling.

TB-500 (Thymosin Beta-4 fragment) (10 mg)
Investigated for cell migration pathways, angiogenesis research, cytoskeletal organization, and musculoskeletal recovery signaling. Laboratory models have examined its influence on tissue regeneration and structural adaptation.

BPC-157 (10 mg)
Studied for soft tissue repair signaling, vascular interaction mechanisms, and inflammatory pathway modulation in controlled research environments. Research has explored its role in connective tissue and gastrointestinal models.

KPV (10 mg)
Evaluated for modulation of inflammatory cytokine signaling, immune pathway regulation, and epithelial barrier research models. Studies have focused on its interaction with localized inflammatory environments.

When researched together, this blend has been evaluated for potential synergistic activity across inflammation regulation, protein synthesis signaling, vascular response pathways, and connective tissue maintenance. Most available literature remains preclinical, with ongoing investigation into mechanism, tissue specificity, and long-term biological activity.

Research-Only Use:

This compound is sold strictly for in vitro laboratory research purposes only. It is not intended for human or veterinary use, nor for diagnostic or therapeutic purposes. No claims are made regarding safety or efficacy in any clinical application.

Disclaimer:

All information provided is for educational and scientific reference only. Statements have not been evaluated by the FDA or any medical regulatory body. This product is not a drug or supplement. Buyer assumes all responsibility for lawful use and compliance with applicable regulations.

Terms of Sale:

By purchasing from Zenergy, you confirm that you are a qualified researcher or institution equipped to handle this material safely. You accept full responsibility for its use and understand that Zenergy assumes no liability for misuse, misinterpretation, or improper application of this compound.